Increasing prevalence of tuberculosis worldwide is driving the growth of the tuberculosis diagnostics market. Rising awareness about early diagnosis and treatment of the disease is also contributing to market growth. Additionally, advancements in diagnostic technologies such as molecular diagnostic tests are further fueling market expansion.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Test Type, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, BioMérieux SA, Hain Lifescience, QIAGEN, Cepheid, Hologic, BD |
Limited access to diagnostic facilities in developing regions remains a major restraint for the tuberculosis diagnostics market. High cost of diagnostic tests and lack of skilled healthcare professionals for accurate diagnosis are also hindering market growth.